These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22809285)

  • 21. The diagnostic value of a brief GnRH analogue stimulation test in girls with central precocious puberty: a single 30-minute post-stimulation LH sample is adequate.
    Houk CP; Kunselman AR; Lee PA
    J Pediatr Endocrinol Metab; 2008 Dec; 21(12):1113-8. PubMed ID: 19189683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life.
    Bizzarri C; Spadoni GL; Bottaro G; Montanari G; Giannone G; Cappa M; Cianfarani S
    J Clin Endocrinol Metab; 2014 Feb; 99(2):433-9. PubMed ID: 24297793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basal serum luteinising hormone cut-off, and its utility and cost-effectiveness for aiding the diagnosis of the onset of puberty in girls with early stages of breast development.
    Wankanit S; Mahachoklertwattana P; Pattanaprateep O; Poomthavorn P
    Clin Endocrinol (Oxf); 2020 Jan; 92(1):46-54. PubMed ID: 31705682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of basal LH in monitoring central precocious puberty treatment in girls.
    Calcaterra V; De Filippo G; Albertini R; Rendina D; Messini B; Monti CM; Bozzola E; Villani A; Bozzola M
    J Pediatr Endocrinol Metab; 2021 Jan; 34(1):45-50. PubMed ID: 33189082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy.
    Neely EK; Silverman LA; Geffner ME; Danoff TM; Gould E; Thornton PS
    Int J Pediatr Endocrinol; 2013 Dec; 2013(1):20. PubMed ID: 24295437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring gonadotropin-releasing hormone analogue (GnRHa) treatment in girls with central precocious puberty: a comparison of four methods.
    Zung A; Burundukov E; Ulman M; Glaser T; Zadik Z
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):885-93. PubMed ID: 25781535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty.
    Lee HS; Yoon JS; Roh JK; Hwang JS
    Endocrine; 2016 Nov; 54(2):497-503. PubMed ID: 27444748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subnormal Growth Velocity and Related Factors During GnRH Analog Therapy for Idiopathic Central Precocious Puberty.
    Muratoğlu Şahin N; Uğraş Dikmen A; Çetinkaya S; Aycan Z
    J Clin Res Pediatr Endocrinol; 2018 Jul; 10(3):239-246. PubMed ID: 29687783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The histrelin implant: a novel treatment for central precocious puberty.
    Hirsch HJ; Gillis D; Strich D; Chertin B; Farkas A; Lindenberg T; Gelber H; Spitz IM
    Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal ranges for immunochemiluminometric gonadotropin assays.
    Neely EK; Hintz RL; Wilson DM; Lee PA; Gautier T; Argente J; Stene M
    J Pediatr; 1995 Jul; 127(1):40-6. PubMed ID: 7608809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GnRH stimulation test in precocious puberty: single sample is adequate for diagnosis and dose adjustment.
    Kandemir N; Demirbilek H; Özön ZA; Gönç N; Alikaşifoğlu A
    J Clin Res Pediatr Endocrinol; 2011; 3(1):12-7. PubMed ID: 21448328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luteinizing Hormone Secretion during Gonadotropin-Releasing Hormone Stimulation Tests in Obese Girls with Central Precocious Puberty.
    Lee HS; Yoon JS; Hwang JS
    J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):392-398. PubMed ID: 27215137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central precocious puberty: a single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment.
    Salerno M; Di Maio S; Gasparini N; Mariano A; Macchia V; Tenore A
    Horm Res; 1998; 50(4):205-11. PubMed ID: 9838241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test.
    Ibáñez L; Potau N; Zampolli M; Virdis R; Gussinyé M; Carrascosa A; Saenger P; Vicens-Calvet E
    J Clin Endocrinol Metab; 1994 Jan; 78(1):30-5. PubMed ID: 7507123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical risk score for central precocious puberty among girls with precocious pubertal development: a cross sectional study.
    You J; Cheng X; Li X; Li M; Yao L; Luo F; Cheng R; Xi L; Ye J
    BMC Endocr Disord; 2021 Apr; 21(1):75. PubMed ID: 33879124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of body mass index on luteinizing hormone secretion in gonadotropin-releasing hormone stimulation tests of boys experiencing precocious puberty.
    Lee HS; Park HK; Ko JH; Kim YJ; Hwang JS
    Neuroendocrinology; 2013; 97(3):225-31. PubMed ID: 22907516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of fluorometric assays in the evaluation of precocious puberty.
    Brito VN; Batista MC; Borges MF; Latronico AC; Kohek MB; Thirone AC; Jorge BH; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3539-44. PubMed ID: 10522992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R; Soros A; Jakubowicz S
    J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty.
    Tung YC; Lee JS; Tsai WY; Hsiao PH
    J Formos Med Assoc; 2007 Oct; 106(10):826-31. PubMed ID: 17964961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study.
    Valenzise M; Nasso C; Scarfone A; Rottura M; Cafarella G; Pallio G; Visalli G; Di Prima E; Nasso E; Squadrito V; Wasniewska M; Irrera P; Arcoraci V; Squadrito F
    Front Pediatr; 2023; 11():1170025. PubMed ID: 37266535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.